Claim that SARS-CoV-2 binds to hemoglobin in red blood cells unsupported and implausible
This claim first appeared on 5 April 2020 on the publishing platform Medium. Written by Andrew Gaiziunas, who has no medical background, the article claims that SARS-CoV-2, the virus causing COVID-19, binds to hemoglobin inside red blood cells and prevents these cells from carrying oxygen. Although the original article has since been removed from Medium, the claim still continues to circulate in the archived form of the article, which has received more than 1.6 million engagements on Facebook. The basis for the claim can be found in a pre-print of a study uploaded to ChemRxiv, which reports the findings of in silico—or computational—analysis of certain SARS-CoV-2 protein sequences, but has not been verified by experimental work in vitro or in vivo.
Packaged inside red blood cells, hemoglobin is a protein comprising four globular protein subunits (called globins), each of which carries an embedded heme group. A heme group is made of an iron ion and another compound called porphyrin (see figure below for a diagram of hemoglobin’s structure). Through the reversible binding of oxygen to the iron ion in heme groups, red blood cells can pick up oxygen in the lungs and deliver it to the rest of the body.
Molecular structure of hemoglobin
Figure—The molecular structure of hemoglobin.
Specifically, Gaiziunas claims that the virus binds to heme, and in doing so, ejects iron from hemoglobin, thus preventing red blood cells from carrying oxygen.
Scientists told Health Feedback that the claim was not supported by experimental and clinical evidence. “There is no direct biological evidence that SARS-CoV-2 proteins interact with hemoglobin. The claim is based on a single study performed purely in silico without proper wet lab validation,” explained Victor Tseng, pulmonologist and assistant professor of medicine at Emory University. Eva Nozik-Grayck, clinician-scientist and critical care specialist at the Children’s Hospital Colorado, stated that “without any experimental evidence, it is dangerous and misleading to make these claims.”
David Irwin, associate professor at the University of Colorado Denver, who studies hemoglobin and hypoxia, questioned the conclusions of the ChemRxiv pre-print that served as the basis for the claim. “The authors show no convincing data to suggest that the [viral] proteins of interest, such as Orf8, etc., actually bind heme other than in modeling theories. Most troubling is that there is no way that we know of to suggest that the virus accesses hemoglobin in red blood cells to attack the heme as described in the manuscript,” he said.
A Medium article authored by Matthew Amdahl, a clinician-scientist and hemoglobin researcher at the University of Pittsburgh, details the numerous problems with Gaiziunas’ hypothesis. Notably, he pointed out that SARS-CoV-2 is larger than the entire hemoglobin protein, but according to Gaiziunas’ hypothesis, would somehow manage to fit into “a space barely large enough for two-atom molecules like oxygen (O2)” in order to eject iron from hemoglobin and bind to porphyrin:
“To put it charitably, this would be an entirely novel and seemingly impossible sort of chemistry, and there is absolutely no scientific evidence that supports such a possibility. It’s this seemingly impossible interaction that forms the foundation of the blog post’s entire argument, and so the remainder of the conclusions drawn by the blogger simply don’t carry any weight.”
Furthermore, clinical evidence from COVID-19 patients contradict Gaiziunas’ hypothesis. Firstly, supposing that the virus did bind to hemoglobin and ejected iron from red blood cells, this would have produced a modified form of hemoglobin that has an altered ability to bind to oxygen, which can be detected by measuring the oxyhemoglobin dissociation constant.
However, Tseng pointed out that co-oximetry, which is used to measure the levels of blood gases like oxygen and carbon dioxide in addition to different forms of hemoglobin, “has failed to detect abnormal species of hemoglobin [in COVID-19 patients]. Furthermore, there is no evidence that the oxyhemoglobin dissociation constant is markedly altered in these patients.”
Secondly, if the virus actually ejected iron from the heme group, “then total iron accumulation in the blood plasma should increase, and there is no clinical evidence of this either,” Irwin added.
The claim that “There is no ‘pneumonia’ nor ARDS” in COVID-19 patients is also demonstrably false, as reports from China and Italy show[2,3]. This Science news article discusses the complications from COVID-19, among which are pneumonia and acute respiratory distress syndrome (ARDS). In clinical guidelines, both the U.S. Centers for Disease Control and Prevention and the World Health Organization also include pneumonia and ARDS as conditions that may need to be managed in COVID-19 patients.
In summary, while scientists have not ruled out a potential link between changes in red blood cell physiology and hypoxia observed in COVID-19 patients, the mechanisms proposed by Gaiziunas are founded on little to no scientific evidence, are highly implausible given what we already know of hemoglobin and the virus, and are contradicted by clinical evidence in COVID-19 patients.